Literature DB >> 10219839

Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations.

E Garello1, S Battista, F Bar, G A Niro, N Cappello, M Rizzetto, G Molino.   

Abstract

Assessment of hepatic function is based on both liver blood tests and functional tests, the extensive application of which is still controversial. The aim of this study was to evaluate the clinical utility of a few selected tests as discriminatory and prognostic indexes: serum albumin, pseudocholinesterase, prothrombin time, as well as galactose elimination capacity and hepatic sorbitol clearance. Two separate studies were performed: Study I to investigate how well these tests assessed severity, and Study II to evaluate their prognostic value. A total of 128 consecutive cirrhotic patients classified according to the Child-Pugh score were included in Study I; Study II was carried out on 47 of these 128 during a two-year follow-up period. Pairwise correlations between all tests and Child-Pugh score yielded higher significant values for liver blood tests than for the functional ones. In Study I functional tests such as galactose elimination capacity and hepatic sorbitol clearance did not appear to be better than conventional biochemical tests in discriminating clinical severity of cirrhotic patients, as defined by Child-Pugh classification. Results of Study II confirmed that in severe liver cirrhosis Child-Pugh score remains the best method for medium- and long-term prognosis and for planning liver transplantation. Functional tests should be reserved for defining the residual functioning liver mass or for studies about functional liver plasma flow.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219839     DOI: 10.1023/a:1026678228967

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Kinetics of galactose elimination.

Authors:  N TYGSTRUP; K WINKLER
Journal:  Acta Physiol Scand       Date:  1954-12-31

Review 2.  Prognostic models in chronic liver disease: validity, usefulness and future role.

Authors:  E Christensen
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

3.  Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.

Authors:  J Zeeh; H Lange; J Bosch; S Pohl; H Loesgen; R Eggers; M Navasa; J Chesta; J Bircher
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

4.  Laboratory tests of hemostasis. The relation to hemorrhage in liver disease.

Authors:  I Spector; M Corn
Journal:  Arch Intern Med       Date:  1967-06

5.  Drugs as indicators of hepatic function.

Authors:  R A Branch
Journal:  Hepatology       Date:  1982 Jan-Feb       Impact factor: 17.425

6.  Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis.

Authors:  I Albers; H Hartmann; J Bircher; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

7.  Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato.

Authors:  F Salerno; G Borroni; P Moser; A Sangiovanni; P Almasio; G Budillon; G Capuano; M Muraca; G Marchesini; M Bernardi; G Marenco; G Molino; L Rossaro; A Solinas; A Ascione
Journal:  J Hepatol       Date:  1996-10       Impact factor: 25.083

8.  The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death.

Authors:  C Merkel; G Marchesini; A Fabbri; S Bianco; G Bianchi; E Enzo; D Sacerdoti; M Zoli; A Gatta
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

9.  Combined evaluation of total and functional liver plasma flows and intrahepatic shunting.

Authors:  G Molino; P Avagnina; M Ballarè; M Torchio; A G Niro; P E Aurucci; M Grosso; C Fava
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

10.  Prognostic indicators in alcoholic cirrhotic men.

Authors:  C Gluud; J H Henriksen; G Nielsen
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

View more
  8 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

2.  Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients.

Authors:  Giovanni Tarantino; Paolo Conca; Domenico Capone; Antonio Gentile; Giuliano Polichetti; Vincenzo Basile
Journal:  Eur J Clin Pharmacol       Date:  2006-07-14       Impact factor: 2.953

3.  Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume.

Authors:  Yi-Ming Li; Fan Lv; Xin Xu; Hong Ji; Wen-Tao Gao; Tuan-Jie Lei; Gui-Bing Ren; Zhi-Lan Bai; Qiang Li
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

5.  Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits.

Authors:  Takashige Yamada; Yoshifumi Kotake; Hiromasa Nagata; Junzo Takeda
Journal:  J Anesth       Date:  2013-06-05       Impact factor: 2.078

6.  Functional hepatic flow in patients with liver cirrhosis.

Authors:  Zheng Pan; Xing-Jiang Wu; Jie-Shou Li; Fang-Nan Liu; Wei-Su Li; Jian-Ming Han
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

7.  Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D.

Authors:  Minaam Abbas; Zaigham Abbas
Journal:  World J Hepatol       Date:  2017-08-08

8.  Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.

Authors:  Brian C Geyer; Katherine E Larrimore; Jacquelyn Kilbourne; Latha Kannan; Tsafrir S Mor
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.